Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2009, p. 697-703, Vol. 47, No. 3
0095-1137/09/$08.00+0 doi:10.1128/JCM.01769-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Yong Zhang,1,
Songtao Xu,1
Pengbo Yu,2
Xiaoping Tian,2
Li Wang,2
Zhonghua Liu,1
Liuying Tang,1
Naiying Mao,1
Yixin Ji,1
Chongshan Li,1
Zhaohui Yang,1,3
Shiwen Wang,1
Jingjun Wang,2
Dexin Li,1 and
Wenbo Xu1*
WHO WPRO Regional Reference Measles Laboratory and State Key Laboratory for Molecular Virology & Genetic Engineering, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China,1 Shanxi Center for Disease Control and Prevention, Xian, China,2 School of Basic Medical Science, Lanzhou University, Lanzhou, China3
Received 13 September 2008/ Returned for modification 3 November 2008/ Accepted 15 December 2008
|
|
|---|
|
|
|---|
Adenoviruses are nonenveloped particles with linear double-stranded DNA. The viral capsid is composed of three main proteins: hexons, penton bases, and fibers. Hexon proteins comprise 919 to 968 amino acids (22) containing serotype-specific epitopes encoded by seven hypervariable regions (HVRs) (6), which are recognized as the most important components of the viruses for serotype identification (24, 26).
Thus far, 52 serotypes of HAdVs have been characterized and classified into seven subgroups or species (subgroups A to G) of the genus Mastadenovirus on the basis of their biological properties and DNA sequence homology (1, 12). HAdV species B has been further classified into two subspecies, namely, B1 (HAdV type 3 [HAdV-3], HAdV-7, HAdV-16, HAdV-21, and HAdV-50) and B2 (HAdV-11, HAdV-14, HAdV-34, and HAdV-35). The B1 viruses are usually associated with respiratory tract infections, while the B2 viruses, except for HAdV-11a and HAdV-14, are associated with kidney and urinary tract infections (16, 21).
The occurrence of repeated outbreaks of HAdV-associated diseases has been described in young people, especially senior high school students, in China. These patients were reported to have an acute respiratory disease that was usually caused by HAdV-3 and HAdV-7 (B1 species) (8, 28, 31). Here, we describe an outbreak of acute respiratory tract infection in a senior high school (a combination of a boarding and commuter school) in Shanxi Province, China, from March to April 2006. Clinical specimens were collected from the patients and healthy people to identify the etiological agent responsible for this outbreak. A detailed analysis of the specimens was performed with respect to the etiology. The identification and molecular characterization of the HAdV strains of species B that were isolated from the specimens constituted the main objective of this study. We concluded that the outbreak of respiratory disease in the senior high school in the Qishan County, Shanxi Province, China, was caused by HAdV-11a, which belongs to species B2.
|
|
|---|
![]() View larger version (17K): [in a new window] |
FIG. 1. Case distribution in the senior high school during the outbreak. On 7 March 2006, a student from a senior high school in Qishan County, Shanxi Province, presented with febrile symptoms. The number of similar cases increased dramatically by 20 March. By 13 April 2006, the outbreak affected a total of 247 students of the same senior high school where the first patient attended school; these cases were identified on the basis of a case definition and by conducting an active search. The duration of the outbreak consisted of three phases of peak incidence, with approximately 1-week intervals between the phases.
|
|
|
|---|
Fifty apparently healthy students from a different senior high school in a different town of the same county were selected as the control population, and serum samples were collected from each student (total number of samples, 50). That senior high school is also a combination of a boarding and commuter school; the distance between the two high schools is more than 40 kilometers, and no case of infection was reported at the school from which the control population was selected.
An enzyme-linked immunosorbent assay (ELISA) was performed to detect bacterial antibodies, and the specimens were cultured to assess them for bacterial growth. They were then prepared for viral detection. All the specimens were dispatched in sterile containers through a cold chain with a controlled low temperature of between 2 and 8°C to the Institute for Viral Disease Control and Prevention in the Chinese Center for Disease Control and Prevention, where the sera and other specimens were stored at –20°C and –80°C, respectively, for further analysis.
Extraction of viral nucleic acid and direct RT-PCR or PCR. The viral nucleic acid was directly extracted from the clinical specimens by using a QIAamp mini-viral RNA extraction kit or a QIAamp DNA minikit (Qiagen, Valencia, CA). Direct reverse transcription-PCR (RT-PCR) or PCR was performed by using different special primer pairs for adenoviruses (forward primer, 5'-ACCCACGATGTGACCACCGA-3', nucleotides [nt] 157 to 176; reverse primer, 5'-TGTCAAAGAATGTGCTGGCC-3', nt 286 to 305; the nucleotide positions are according to the hexon gene of HAdV-3 [GenBank accession number AF542126], and the primers were designed at the China Center for Disease Control and Prevention and are specific for species B of HAdV), influenza virus (27), measles virus (29), rubella virus (33), mumps virus (11), parainfluenza virus (7), respiratory syncytial virus (32), and human enteroviruses (30).
Cell culture and virus isolation. The 21 clinical specimens, including 18 throat swab specimens collected from the patients and each of the hydrothorax fluid, sputum, and serum samples from the patient who died, were separately inoculated into HEp-2 cells and were cultured in a maintenance medium (minimal essential medium containing 2% fetal calf serum, 100 U/ml penicillin G, 100 µg/ml streptomycin) at 37°C in a closed system in the absence of a CO2 incubator. At the end of the observation period, if no cytopathic effect (CPE) was observed in the cultures, they were further cultured for another 7 days. Cultures exhibiting an adenovirus-like CPE were passaged again to confirm the presence of the virus. Primary identification of positive isolates was performed by PCR with adenovirus-specific primers.
Neutralization test. The entire virion of the HAdV strain isolated and identified was used as the neutralization virus, and the 50% cell culture infective dose (CCID50)/50 µl was calculated by using the formula of Kärber (14). The stored serum samples were inactivated at 56°C for 30 min, diluted 20 times with the maintenance medium, and filtered through a 0.22-µm-pore-size filter membrane. Several dilutions of the serum samples (from 1:20 to 1:2,560) were prepared, and 50 µl of each dilution was added to four wells of a 96-well microplate. Furthermore, 50 µl of the viral antigen, diluted to a CCID50 of 100, was added to each well, the contents were mixed well, and the plate was incubated for 2 h in an open system in the presence of 5% CO2. The HEp-2 cell suspension was then added to each well. Positive and negative controls were prepared, the plate was incubated once again in the open system in the presence of 5% CO2, and the CPE was observed daily.
ELISA. The 18 samples from the acute phase collected from the 18 patients and the 50 serum samples collected from the control population were tested to detect HAdV immunoglobulin A (IgA) by using an ELISA Classic adenovirus IgA kit (Institute Virion/Serion GmbH, Würzburg, Germany). This kit enables the detection of serum antibodies against all serotypes of HAdV that are pathogenic for humans.
Extraction of viral DNA and conventional PCR. DNA was extracted from the clinical specimens by using the QIAamp DNA minikit (Qiagen, Valencia, CA). PCR was performed with a 50-µl reaction mixture containing 1x PCR buffer, 2 mM MgSO4, 0.2 mM each deoxynucleoside triphosphate (Promega), 1 U high-fidelity Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA), 0.2 µM each primer (listed in Table 1), and 2.5 µl of the template DNA. An initial denaturation of 94°C for 1 min was followed by 35 cycles of dentauration at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 68°C for 5 min in a GeneAmp 9700 thermal cycler (Applied Biosystems). The amplification products were analyzed by electrophoresis of the samples in 1% agarose gels and were visualized with ethidium bromide under UV light.
|
View this table: [in a new window] |
TABLE 1. Primers used for amplification and sequencing of the entire hexon gene
|
Sequence analysis. The sequence data were stored as standard chromatogram format (.ab1) files and were analyzed with Sequencher software (version 4.0.5; GeneCodes, Ann Arbor, MI). The nucleotide sequence homology was inferred from the identity scores obtained by using the BLASTn program (National Center for Biotechnology Information, Bethesda, MD). Recombination analysis was performed by using SimPlot software (Johns Hopkins University School of Medicine, Baltimore, MD) (17). Sequence alignments were created with BioEdit sequence alignment editor software (version 5.0.9; Tom Hall, North Carolina State University) (9), and a phylogenetic dendrogram was constructed by the neighbor-joining method with the MEGA program (Sudhir Kumar, Arizona State University); the reliability of the tree was estimated with 1,000 bootstrap pseudoreplicates (25).
Nucleotide sequence accession numbers. The nucleotide sequence of the entire hexon gene for strain HAdV11-QS/ShX/CHN/2006, which was determined in this study, has been deposited in the GenBank nucleotide sequence database under accession number DQ874353.
|
|
|---|
PCR or RT-PCR was performed with a total of 21 clinical specimens (18 throat swab specimens collected from the 18 patients and 1 sample each of hydrothorax fluid, sputum, and serum from the sole patient who died) and primer sets specific for viruses, including species B of HAdV, influenza virus (27), measles virus (29), rubella virus (33), mumps virus (11), parainfluenza virus (7), respiratory syncytial virus (32), and human enteroviruses (30). Positive results were obtained only for species B of HAdV. Of all the clinical specimens examined, DNA from 13 specimens, including 3 specimens obtained from the sole patient who died, was successfully amplified by PCR with primers specific for 149 bp of the partial hexon gene of HAdV species B. Further identification by sequence determination and BLAST sequence analysis revealed that all the sequences had the highest grade of homology (100%) with species B of HAdV (strain RKI-2797/04, HAdV-11a; GenBank accession number AY972815). Thus, no evidence of bacterial or viral infections except adenovirus infection was found.
Molecular analysis of the HAdV strain. All 21 clinical specimens were separately inoculated into HEp-2 cells, and a characteristic adenovirus-like CPE was observed in the HEp-2 cells for 5 throat swab samples and 1 hydrothorax fluid sample. In all these cases, a CPE was observed within two passages after inoculation, and the entire hexon gene was successfully amplified by PCR from all samples with adenovirus-specific primers to obtain the predicted products of 3,449 bp. Furthermore, sequence determination revealed that six viral isolates exhibited 99.9% to 100% homology in their nucleic acid sequences. Therefore, it was concluded that all the patients were infected with the same virus. A viral strain designated HAdV11-QS was isolated from the hydrothorax fluid sample of the sole patient who died, and the strain was used for phylogenetic analysis.
In order to investigate the genetic relationships between strain HAdV11-QS and other HAdV strains, a phylogenetic analysis was conducted on the basis of the entire hexon gene (nt 18255 to 21101, Slobitski strain) with 18 virus strains representing the seven HAdV species (Fig. 2a). All HAdVs can be classified into seven species, i.e., species A to G, on the basis of bootstrap support values. Strain HAdV11-QS could definitely be clustered within HAdV-11 since it exhibited the highest degree of nucleotide sequence identity with the HAdV-11 strain (Slobitski strain, HAdV-11p; identity, 2,794/2,848 nucleotides [98%]; gaps, 6/2,848 nucleotides [0%]).
![]() View larger version (23K): [in a new window] |
FIG. 2. Phylogenetic analysis of HAdV: (a) the entire hexon gene (nt 18255 to 21101, Slobitski strain), (b) the 5' end of the partial hexon gene covering HVRs 1 to 7 (nt 18361 to 19801, Slobitski strain), and (c) the 3' end of the partial hexon gene outside the HVRs (nt 19802 to 21101, Slobitski strain). The phylogenetic tree was generated by using the neighbor-joining method; bootstrap values are provided for the basal nodes of each species (species A to G). The GenBank accession numbers for each HAdV are as follows: HAdV-12, X73487; HAdV-31, DQ149611; HAdV-3, X76549; HAdV-7, AF515814; HAdV-11a, AY972815; HAdV-11p, AF532578; HAdV-14, AY803294; HAdV-21, AY008279; HAdV-34, AB052911; HAdV-35, AB330116; HAdV-50, DQ149643; HAdV-2, AJ293903; HAdV-5, AF542130; HAdV-17, AB330098; HAdV-48, U20821; HAdV-4, AF065063; HAdV-40, X51782; HAdV-41, AB330122; and HAdV-52, DQ923122. Strain HAdV11-QS could definitely be identified as an HAdV-11a strain belonging to the B2 species, but recombination with the sequence of HAdV-14 was found at the 3' end of the hexon gene.
|
In order to clarify the possible recombination events, a similarity plot with a sliding window of 200 residues was used to analyze the relationship of strain HAdV11-QS to species B strains of HAdV (Fig. 3). When the sequence of the entire hexon gene of strain HAdV11-QS was used as the query sequence and compared to the sequences of eight strains representing the eight serotypes of HAdV species B, the 5' end of the strain HAdV11-QS hexon gene covering HVRs 1 to 7 exhibited the highest degree of similarity to the sequence of HAdV-11p (prototype strain Slobitski), while the 3' end of the strain HAdV11-QS hexon gene outside the HVRs exhibited the highest degree of similarity to the sequence from HAdV-14 (prototype strain de Wit), although all strains of species B2 (HAdV-11p, HAdV-14, HAdV-34, and HAdV-35) exhibited higher degrees of homology to each other; this finding shows that the sequence of the 3' end of the strain hexon gene outside the HVRs of strain HAdV11-QS may be a recombinant with the sequence of HAdV-14.
![]() View larger version (24K): [in a new window] |
FIG. 3. Similarity of the entire hexon sequence (nt 18255 to 21101, Slobitski strain) of strain HAdV11-QS compared with the sequences of species B strains of HAdV. Windows, 200 bp; step, 20 bp. The Kimura model with the Jukes-Cantor correction was used. The vertical axis indicates the percent nucleotide identities between strain HAdV11-QS and eight strains representing eight serotypes of HAdV species B. The horizontal axis indicates the nucleotide positions of the entire hexon gene. GenBank accession numbers for each HAdV are as follows: HAdV-3, X76549; HAdV-7, AF515814; HAdV-11p, AF532578; HAdV-14, AY803294; HAdV-21, AY008279; HAdV-34, AB052911; HAdV-35, AB330116; and HAdV-50, DQ149643. The horizontal axis at the bottom indicates the positions of HVRs 1 to 7.
|
We used the entire virion of the HAdV strain isolated and identified (strain HAdV11-QS) as the neutralization virus; the CCID50 was determined by using the formula of Kärber (14) to be approximately 105.5 CCID50s/50 µl. Conventional neutralization tests were performed with three pairs of paired serum samples (with each pair consisting of one sample from the acute phase and one sample from the convalescent phase from the same patient). The results (Table 2) revealed that the neutralization titers of the convalescent-phase samples were four times higher than those of the acute-phase samples for all three pairs. This finding also suggests that HAdV-11 was associated with this outbreak.
|
View this table: [in a new window] |
TABLE 2. Results of a conventional neutralization test performed with three pairs of serum samples and strain HAdV11-QS
|
|
|
|---|
In recent years, molecular techniques have played a key role in disease control because they enable rapid and early diagnosis. In this study, the serotype and the genotype of the HAdV strain involved were identified by performing PCR and sequencing of the entire hexon gene. HVRs 1 to 7 of the HAdV hexon gene encode serotype-specific epitopes and have been described for use for the serotype identification of HAdV (24, 26). Furthermore, the results of the sequencing of HVRs 1 to 7 of the HAdV hexon gene appeared to correlate well with those of serological typing and other molecular typing methods (20). For these reasons, use of the 1,441-bp sequence (nt 18361 to 19801, Slobitski strain) covering HVRs 1 to 7, which was used in this study, should be considered for precise molecular typing. On the basis of such molecular typing results, the viruses isolated from this outbreak belonged to HAdV-11a. However, recombination is a well-known feature in HAdV genetics and an important force driving the evolution of HAdV; in general, intraspecies recombination is observed much more frequently than interspecies recombination (19). In this study, both the analysis of the phylogenetic relationship and the similarity plot indicated that the sequence of the 3' end of the hexon gene outside the HVRs of strain HAdV11-QS may be a recombinant with the sequence of the HAdV-14 strain of species B2; this is an instance of intraspecies recombination.
In this study, we obtained detailed clinical descriptions of the outbreak. The clinical course and the available epidemiological data were well consistent with the clinical course and epidemiological data described in previous reports on HAdV-associated acute respiratory diseases. In the outbreak studied here, most of the affected individuals (97.2%) were students of a senior high school. The commonly recognized route of transmission is through respiratory droplets and close contact, which leads to the rapid and widespread dissemination of HAdV in crowded places. Similar events have been reported to occur in military camps and day care centers in China and other countries (4). The early detection of HAdV infections should receive more attention from clinicians and public health officials when they are evaluating and responding to outbreaks.
HAdV-11 was first isolated from a fecal sample from a child diagnosed with poliomyelitis in 1954; poliovirus type I was also recovered from that patient. HAdV-11 has been reported to be associated with upper and lower respiratory illnesses; with hemorrhagic cystitis in children and young adults, especially in renal transplant recipients; and occasionally with endemic hemorrhagic conjunctivitis (16). In 1991, HAdV-11 strains were classified into at least two genome types, designated HAdV-11p and HAdV-11a, on the basis of similarities in fragment comigration patterns during restriction genome typing (16). These two types exhibit different tropisms: HAdV-11a infects respiratory epithelial cells, while HAdV-11p infects renal cells. HAdV-11a strains were more frequently isolated in China from 1965 to 1985 (16). Although HAdV-11 infections have not been reported for more than 20 years, the etiological analysis of this outbreak reveals that HAdV-11a has continued to exist and circulate in China. Furthermore, phylogenetic analysis revealed that this strain is also circulating in other countries, such as Turkey (4). This assumption is based on the evidence that the nucleotide sequence of strain HAdV11-QS was exactly identical to the partial hexon gene sequence of strain RKI-2797/04 (GenBank accession number AY972815) isolated in Turkey. HAdV-11a was also isolated from patients with acute respiratory tract infections in Spain and Latin America (13).
Most children and young adults infected with HAdV have only mild illnesses with respiratory symptoms, and this virus seldom causes severe illness. However, the host immune response may be the key determinant of the clinical course of HAdV infection. The sole patient who died during the outbreak had bone marrow megaloblastic anemia as an underlying disease, and HAdV coinfection may have contributed to the onset of a life-threatening disease.
Since little is known about the dynamics of HAdV-11, which was involved in the emergence of pathogens causing acute febrile respiratory disease in the senior high school students, studies investigating the persistence and transmission of this agent within populations should be conducted by the use of continuous surveillance. In this study, few people (12%) in the control population also tested positive for HAdV IgA; this may have been due to the presence of an inapparent infection, which may also contribute to HAdV transmission. Thus, it is not possible to predict whether HAdV-11 will persist as a significant cause of acute respiratory disease outbreaks in high schools.
HAdV-14, which also belongs to the B2 species, has recently emerged and has caused outbreaks of severe respiratory disease in the United States. From March to June 2007, cases of HAdV-14-induced respiratory illness were confirmed in 140 patients in Oregon, Washington, and Texas. Of these 140 patients, 53 (38%) patients were hospitalized, 24 (17%) patients were admitted to intensive care units; and 9 (5%) patients died (2, 18). In this study, recombination between HAdV-11a and HAdV-14 was found. However, it was very difficult to identify the time of recombination and the manner in which it occurred, but it seemed that HAdV-14 also circulated in China at some time.
Acute respiratory diseases due to HAdV are primarily attributed to HAdV-4, HAdV-7, HAdV-3, and HAdV-21. Thus, HAdV species B2, including HAdV-11 and HAdV-14, may pose a new global challenge with regard to acute respiratory diseases. Although HAdV isolates of this species seldom cause respiratory infections, this possibility cannot be overlooked and should be carefully considered. Additionally, such HAdV infections may be underreported, especially if the infections are mild or asymptomatic; hence, the need for the establishment and improvement of both epidemiological and virological surveillance for HAdV infections in China should be emphasized.
This work was supported by grant 2007AA02Z463 from the Ministry of Science and Technology of the People's Republic of China.
None of the authors reports a conflict of interest.
Published ahead of print on 24 December 2008. ![]()
These authors made equal contributions to this study. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»